The foundational Lustre protocol. Sermorelin restores growth hormone signalling — improving sleep architecture, daytime energy, and the cellular repair that slows with age.
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). Unlike direct HGH injections, it works with your body's own pituitary gland — stimulating it to release natural growth hormone in the pulses it was designed to produce. GH secretion declines significantly from your late 20s onward, and Sermorelin is one of the most clinically validated ways to restore it.
Administered before sleep, Sermorelin triggers the overnight GH pulse that the body naturally relies on for tissue repair, muscle maintenance, fat metabolism, and immune function. As GH levels normalise, patients typically notice: deeper, more restorative sleep within the first few weeks; improved energy and recovery; gradual improvements in skin quality and body composition over 3–6 months.
Women experiencing declining energy, disrupted sleep, slower recovery, or the general sense that the body is not restoring itself the way it used to. An ideal entry point into peptide therapy.
Most patients report noticeable improvements in sleep depth and morning energy within 2–4 weeks. The full range of benefits — including skin and body composition changes — becomes apparent over 3–6 months.
No — and the distinction matters. Sermorelin stimulates your pituitary to produce GH naturally, rather than introducing synthetic HGH. This preserves the body's own feedback mechanisms and is associated with a more favourable side effect profile.
Your provider will typically request baseline IGF-1 levels before prescribing Sermorelin. We order labs to your nearest LabCorp or you can upload a recent panel from your physician.
Yes — The Recovery Protocol and The Glow Protocol are one of the most common stacks at Lustre. Your provider will advise on optimal timing and dosing for the combination.
Compounded peptides are prescribed off-label for wellness, performance, and recovery goals under the supervision of a licensed medical provider. They are not intended to diagnose, treat, cure, or prevent any disease.
All peptides dispensed by Lustre Health are prescription-only medications requiring a valid prescription from a licensed provider.
Compounded medications are not FDA-approved drug products. They are prepared by state-licensed 503A compounding pharmacies under USP Chapter 797 standards.
Peptides may interact with insulin, hormone therapies, and immunosuppressants. Disclose all medications to your provider.
Subcutaneous injection. Full training provided with your first shipment.